(R)-3-((1-(cyclopropanecarbonyl)pyrrolidin-3-yl)methyl)-2-(4-(1-methyl-1H-indazol-5-yl)phenyl)-1,3-diazaspiro[4.4]non-1-en-4-one

ID: ALA4129240

PubChem CID: 117999149

Max Phase: Preclinical

Molecular Formula: C30H33N5O2

Molecular Weight: 495.63

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  Cn1ncc2cc(-c3ccc(C4=NC5(CCCC5)C(=O)N4C[C@@H]4CCN(C(=O)C5CC5)C4)cc3)ccc21

Standard InChI:  InChI=1S/C30H33N5O2/c1-33-26-11-10-24(16-25(26)17-31-33)21-4-6-22(7-5-21)27-32-30(13-2-3-14-30)29(37)35(27)19-20-12-15-34(18-20)28(36)23-8-9-23/h4-7,10-11,16-17,20,23H,2-3,8-9,12-15,18-19H2,1H3/t20-/m1/s1

Standard InChI Key:  CVEGCVNNECJUTJ-HXUWFJFHSA-N

Molfile:  

     RDKit          2D

 37 43  0  0  0  0  0  0  0  0999 V2000
   22.5266  -11.0133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8168  -10.6047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2088  -11.1536    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5429  -11.9015    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3574  -11.8147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4832  -11.2894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.3027  -11.2905    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4796   -9.8786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.0722  -10.5878    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.2556  -10.5921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.8455   -9.8799    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0250   -9.8820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.6135  -10.5956    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0328  -11.3044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.8520  -11.2988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.3022   -9.8758    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.7129  -10.5833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5129  -10.4061    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.5941   -9.5915    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.8443   -9.2639    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.1269  -10.9541    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7922  -10.5991    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3065   -9.9387    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.5304  -10.1946    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3122  -11.2650    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.5596   -9.1563    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3623   -8.9827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9748   -9.5227    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.6806   -9.1109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.5070   -8.3082    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.6898   -8.2266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0552   -7.6942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8594   -7.8604    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7990   -6.9141    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.4720   -8.4042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.6382   -7.5999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8641   -9.7116    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  1  1  0
  6  7  2  0
  7 17  1  0
 16  8  1  0
  8  9  2  0
  9  6  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  9 10  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 16  1  0
 18 21  1  0
 13 22  1  0
 22 23  1  0
 23 24  1  0
 24  1  1  0
  1 25  1  0
 25 22  2  0
 23 26  1  0
 27 26  1  1
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 27  1  0
 30 32  1  0
 32 33  1  0
 32 34  2  0
 35 33  1  0
 36 35  1  0
 33 36  1  0
 24 37  2  0
M  END

Alternative Forms

1. Parent:

   

   ALA4129240

   3-[[(3R)-1-(cyclopropanecarbonyl)pyrrolidin-3-yl]methyl]-2-[4-(1-methylindazol-5-yl)phenyl]-1,3-diazaspiro[4.4]non-1-en-4-one

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 495.63

Molecular Weight (Monoisotopic): 495.2634

AlogP: 4.40

#Rotatable Bonds: 5

Polar Surface Area: 70.80

Molecular Species: NEUTRAL

HBA: 5

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): 7

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 3.60

CX LogP: 3.74

CX LogD: 3.74

Aromatic Rings: 3

Heavy Atoms: 37

QED Weighted: 0.53

Np Likeness Score: -1.01

References

1. Lu T, Schubert C, Cummings MD, Bignan G, Connolly PJ, Smans K, Ludovici D, Parker MH, Meyer C, Rocaboy C, Alexander R, Grasberger B, De Breucker S, Esser N, Fraiponts E, Gilissen R, Janssens B, Peeters D, Van Nuffel L, Vermeulen P, Bischoff J, Meerpoel L..  (2018)  Design and synthesis of a series of bioavailable fatty acid synthase (FASN) KR domain inhibitors for cancer therapy.,  28  (12): [PMID:29779975] [10.1016/j.bmcl.2018.05.014]

Source

Source(1):

• Scientific Literature